Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis

Overview of attention for article published in Cochrane database of systematic reviews, January 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 2 public wall posts from 1 users.

#CochranePodcast What are the benefits and risks of drugs acting on the immune system to treat relapsing-remitting #MultipleScler…

What are the benefits and risks of drugs acting on the immune system to treat relapsing‐remitting #multiplesclerosis? #RRMS 📚 🔍…